News Releases | Seer, Inc.

Skip to main navigation

Site - Logo

Site - Investor Relations

Overview
Stock
- Stock Quote & Chart
- Analyst Coverage
News & Events
Financials
- SEC Filings
- Quarterly Results
Governance
Resources

News Releases

Year

May 4, 2022

Seer Reports First Quarter 2022 Financial Results

April 28, 2022

Seer to Present at the BofA Securities 2022 Healthcare Conference

April 7, 2022

Seer to Report First Quarter Financial Results on May 4, 2022

March 16, 2022

Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer

March 14, 2022

Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of Sciences

February 28, 2022

Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook

February 22, 2022

Seer to Present at the Cowen 42nd Annual Health Care Conference

February 1, 2022

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

January 10, 2022

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

January 10, 2022

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

Site - Logo Footer

Site - Company Pages

Seer.bio

Site - Investor Relations Primary

Investor Relations

Site - Social

LinkedIn
Twitter

© 2022 Seer, Inc. All rights reserved.

Search Investor Relations